22157.jpg
Psoriasis Drugs Market (2023-2034) to Grow by $28.85 Billion - Global and Regional Growth Opportunities for Hospital, Retail, and Online Pharmacies with Profiles of the Top 10+ Market Players
May 30, 2024 06:13 ET | Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Global Psoriasis Drugs Market" report has been added to ResearchAndMarkets.com's offering.The global psoriasis drugs market accounted for USD 12.41...
22157.jpg
Immunology Collaboration and Licensing Agreements Analysis Report 2024 with Directory of Deals Signed Since 2016 - Company A-Z, Therapy Focus and Technology Type
May 16, 2024 10:45 ET | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Immunology Collaboration and...
22157.jpg
Global Xerostomia Therapeutics Analysis & Forecast to 2024-2034: $3.69 Billion Market Expanding Amid Growing Cases of Parkinson's, Hypertension, and Diabetes
May 13, 2024 05:51 ET | Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Global Xerostomia Therapeutics Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
22157.jpg
REGN4461 (Mibavademab) for Lipodystrophy in 7MM: Market Size, Sales, Forecasts, and Emerging Insights 2019-2023, 2024-2032
April 30, 2024 04:31 ET | Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "REGN4461 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Innovative Seborrhea Treatments on the Horizon as Pipeline Report Reveals Promising Drug Candidates for 2024
April 26, 2024 04:36 ET | Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Seborrhea - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. Seborrhea, a chronic skin condition often...
22157.jpg
Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm
April 25, 2024 07:43 ET | Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offeringThe global medical...
22157.jpg
Autoimmune Collaboration and Licensing Deals Report 2024: Provides Details of 882 Autoimmune Deals Dating Back to 2016 by Company, Headline Value, Therapeutic Area and Technology Type
April 24, 2024 04:24 ET | Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Autoimmune Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Autoimmune Collaboration and...
22157.jpg
Maveropepimut-S (MVP-S, previously known as DPX-Survivac) Drug Research Report 2024: 7 Major Markets Size, Forecasts, and Emerging Insights 2019-2032
April 17, 2024 09:37 ET | Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "DPX-Survivac Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
China Hydronidone (F-351) Market Size, Forecast, and Emerging Insights, 2019-2023 and 2024-2032
April 16, 2024 05:03 ET | Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "China F-351 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."F-351 Market Size,...
22157.jpg
Ovarian Cancer Opportunity Assessment Report 2024: A Blockbuster Market that is Expected to Grow from $3.3 Billion in 2022 to $4.1 Billion in 2032 with ImmunoGen, AstraZeneca, Merck, & GSK Dominating
April 09, 2024 07:02 ET | Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.Ovarian Cancer is one of the most...